Interferon-β1A-induced polyarthritis in a patient with the HLA- DRB1*0404 allele

Arthritis and Rheumatism

Volumn 42, Issue 3, 1999, Pages 569-573

  Levesque, Marc C ^a   Ward, Frances E ^a   Jeffery, Douglas R ^b   Weinberg, J Brice ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; BETA INTERFERON; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN; IMMUNOLOGICAL ADJUVANT;

AGED; ALLELE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CASE REPORT; DRUG EFFECT; FEMALE; HLA TYPING; HUMAN; MULTIPLE SCLEROSIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; ARTHRITIS; CHEMICALLY INDUCED DISORDER; GENETICS; REVIEW;

ADJUVANTS, IMMUNOLOGIC; AGED; ALLELES; ARTHRITIS; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERFERON-BETA;

EID: 0032588514     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199904)42:3<569::AID-ANR23>3.0.CO;2-M     Document Type: Article

References (32)

1. Durum SK, Oppenheim JJ. Proinflammatory cytokines and immunity. In: Paul WE, editor. Fundamental immunology. New York: Raven Press; 1993. p. 815-9.
2. Bansil S, Cook SD, Rohowsky-Kochan C. Multiple sclerosis: immune mechanism and update on current therapies. Ann Neurol 1995;37:S87-101.
3. Vial T, Descotes J. Immune-mediated side-effects of cytokines in humans. Toxicology 1995;105:31-57.
4. Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992;117:801-6.
5. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
6. Jacobs LD, Cookfair DL, Rudick RA, Herndom RM, Richert JR, Salazar AM, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis: the Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol 1996;39: 285-94.
7. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-85.
8. McMurray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997;26:689-701.
9. Midgard R, Gronning M, Riise T, Kvale G, Nyland H. Multiple sclerosis and chronic inflammatory diseases: a case-control study. Acta Neurol Scand 1996;93:322-8.
10. Shiozawa S, Shiozawa K, Kita M, Kishida T, Fujita T, Imura S. A preliminary study on the effect of alpha-interferon treatment on the joint inflammation and serum calcium in rheumatoid arthritis. Br J Rheumatol 1992;31:405-8.
11. Ardicoglu O, Koseoglu F, Koca I. Lack of effect of recombinant alpha interferon in the treatment of rheumatoid arthritis [letter]. Scand J Rheumatol 1993;22:204-5.
12. Jabaily JA, Thompson JS. Effects of interferon β-1B in rheumatoid arthritis: a case report [letter]. Arthritis Rheum 1997;40:1370.
13. Conlon KC, Urba WJ, Smith JWD, Steis RG, Longo DL, Clark JW. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990;65:2237-42.
14. Ferrazzi V, Jorgensen C, Sany J. Alpha-interferon therapy for leukemia or active viral hepatitis C in patients with rheumatoid arthritis [abstract]. Arthritis Rheum 1994;37 Suppl 9:S246.
15. Makino Y, Tanaka H, Nakamura K, Fujita M, Akiyama K, Makino I. Arthritis in a patient with psoriasis after interferon-alpha therapy for chronic hepatitis C. J Rheumatol 1994;21:1771-2.
16. Chan GC, Lee SS, Yeoh EK. Mono-arthritis in a chronic hepatitis B patient after alpha-interferon treatment. J Gastroenterol Hepatol 1992;7:432-3.
17. Chazerain P, Meyer O, Kahn MF. Rheumatoid arthritis-like disease after alpha-interferon therapy [letter]. Ann Intern Med 1992;116:427.
18. Chung A, Older SA. Interferon-alpha associated arthritis. J Rheumatol 1997;24:1844-5.
19. D'Hondt L, Delannoy A, Docquier C. Hypothyroidism and arthritis during interferon therapy. Clin Rheumatol 1993;12:415-7.
20. Kiely PD, Bruckner FE. Acute arthritis following interferon-alpha therapy [letter]. Br J Rheumatol 1994;33:502-3.
21. Lombardini F, Taglione E, Riente L, Pasero G. Psoriatic arthritis with spinal involvement in a patient receiving alpha-interferon for chronic hepatitis C. Scand J Rheumatol 1997;26:58-60.
22. Maccari S, Bassi C, Giovannini AG, Plancher AC. A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy. Clin Rheumatol 1991;10:452-4.
23. Nadir F, Fagiuoli S, Wright HI, Nadir I, Hopp E, Gavaler J, et al. Rheumatoid arthritis: a complication of interferon therapy. J Okla State Med Assoc 1994;87:228-30.
24. Pittau E, Bogliolo A, Tinti A, Mela Q, Ibba G, Salis G, et al. Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C. Clin Exp Rheumatol 1997;15:415-9.
25. Ueno Y, Sohma T. Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma [letter]. Ann Intern Med 1992;117:266-7.
26. Alsalameh S, Manger B, Kern P, Kalden J. New onset of rheumatoid arthritis during Interferon b-1B treatment in a patient with multiple sclerosis: comment on the case report by Jahaily and Thompson [letter]. Arthritis Rheum 1998;41:754.
27. Weyand CM, Goronzy JJ. Pathogenesis of rheumatoid arthritis. Med Clin North Am 1997;81:29-55.
28. Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-6.
29. Hertzog PJ, Emery P, Cheetham BF, Mackay IR. Linnane AW. Interferons in rheumatoid arthritis: alterations in production and response related to disease activity. Clin Immunol Immunopathol 1988;48:192-201.
30. St. Clair EW, Wilkinson WE, Lang T, Sanders L, Misukonis MA, Gilkeson GS, et al. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med 1996;184:1173-8.
31. Clancy RM, Abramson SB. Nitric oxide: a novel mediator of inflammation. Proc Soc Exp Biol Med 1995;210:93-101.
32. Sharara AI, Perkins DJ, Misukonis MA, Chan SU, Dominitz JA, Weinberg JB. Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J Exp Med 1997;186:1495-502.